Global Interstitial Cystitis Market - Industry Trends and Forecast to 2029

Global Interstitial Cystitis Market - Industry Trends and Forecast to 2029

The global interstitial cystitis market is projected to register a substantial CAGR of 10.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

By Severity (Mild to Moderate and Moderate to Severe), Treatment Type (Medications, Bladder Instillations, Botulinum Toxin A, Nerve Stimulation and Surgery), Route of Administration (Oral, Parenteral, Intravesical, Topical, and Others), Mode of Purchase (Over The Counter and Prescription), Patient Type (Pediatric and Adults), End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East and Africa), Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the global interstitial cystitis market are:
• Rise in prevalence of interstitial cystitis
• Increase in the geriatric population

Market Players

Some of the major players operating in the global interstitial cystitis market are:
• Alvogen
• Hikma Pharmaceuticals
• Sandoz AG
• Sun Pharmaceutical Industries Ltd.
• Accord-UK Ltd
• Avet Pharmaceuticals Inc.
• Lannett
• Viatris Inc.
• Pfizer, Inc.
• Strides Pharma Science Limited
• GlaxoSmithKline plc.
• Prestige Consumer Healthcare Inc
• Amneal Pharmaceuticals LLC
• Zydus Pharmaceuticals, Inc.
• Apotex Inc.
• Aurobindo Pharma USA
• VistaPharm, Inc.
• Dr. Reddy’s Laboratories, Inc.
• Teva Pharmaceuticals, Inc.
• Bayer AG
• Reckitt Benckiser Group PLC
• Janssen Pharmaceuticals, Inc.Companies

• Alvogen
• Hikma Pharmaceuticals
• Sandoz AG
• Sun Pharmaceutical Industries Ltd.
• Accord-UK Ltd
• Avet Pharmaceuticals Inc.
• Lannett
• Viatris Inc.
• Pfizer, Inc.
• Strides Pharma Science Limited
• GlaxoSmithKline plc.
• Prestige Consumer Healthcare Inc
• Amneal Pharmaceuticals LLC
• Zydus Pharmaceuticals, Inc.
• Apotex Inc.
• Aurobindo Pharma USA
• VistaPharm, Inc.
• Dr. Reddy’s Laboratories, Inc.
• Teva Pharmaceuticals, Inc.
• Bayer AG
• Reckitt Benckiser Group PLC
• Janssen Pharmaceuticals, Inc.


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.